|
||||||
|
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() | |
![]() |
Gene: ENSG00000243364 |
Summary for EFNA4 |
Gene summary |
| Gene information | Ensembl ID | ENSG00000243364 | Gene symbol | EFNA4 |
| Gene name | ephrin A4 | |
| HGNC | 3224 | |
| Entrez ID | 1945 | |
| Gene type | protein_coding | |
| Synonyms | EFNA4|LERK4 | |
| UniProtAcc | P52798 |
Drugs associated with this gene(DrugBank). |
| Gene ID | Gene Symbol | Drug ID | Drug Name | Drug Type |
Cancer therapeutic drugs associated with this gene(NCI). |
| Gene ID | Gene Name | Drug ID | Drug Name | Drug Type | Cancer |
Top |
Structure and expression level for EFNA4 |
AS events and RNA A-to-I editing events of the gene in TCGA based on Genvode V22 structure.∗For more information on exon skipping events please check the ExonskipDB database. ∗For more information on exon skipping events please check the CAeditome database. |
Landscape of gene expressions across multiple cancer types. |
Differentially expressed gene analysis between tumor male and tumor female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
Differentially expressed gene analysis between tumor male and normal male samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| EFNA4 | 9.83e+02 | 1.98e+00 | 2.49e-01 | 7.92e+00 | 2.36e-15 | 1.71e-13 | BLCA |
| EFNA4 | 6.98e+02 | 2.26e+00 | 4.93e-01 | 4.59e+00 | 4.51e-06 | 2.78e-05 | CHOL |
Differentially expressed gene analysis between tumor female and normal female samples. |
| Coding Name | Base Mean | log2FoldChange | lfcSE | Stat | P value | P.adjust Value | Cancer Type |
| EFNA4 | 1.42e+03 | 1.27e+00 | 9.51e-02 | 1.34e+01 | 8.52e-41 | 6.34e-40 | BRCA |
| EFNA4 | 1.08e+03 | 1.09e+00 | 2.22e-01 | 4.93e+00 | 8.42e-07 | 7.50e-06 | READ |
Top |
Sex-biased somatic mutation for EFNA4 |
| ∗For more information on exon skipping events please check the ExonskipDB database. |
| Gene ID | Cancer Type | Hugo Symbol | Male | Female | pval | or | ci.up | ci.low | adjPval |
Top |
DNA methylation with beta values for EFNA4 |
Landscape of DNA methylation across multiple cancer types. |
Differentially expressed CpG sites between male tumor and female tumor patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg11491247 | chr1:155063054 | CGI:chr1:155062449-155064102 | promoter | 2.65e-01 | 1.62e-01 | 2.93e+00 | 3.41e-03 | 1.74e-02 | 1.02e-01 |
| BRCA | cg16905506 | chr1:155063272 | CGI:chr1:155062449-155064102 | promoter | 3.18e-01 | 1.96e-01 | 2.53e+00 | 1.13e-02 | 2.79e-02 | 1.22e-01 |
Differentially expressed CpG sites between male tumor and male normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| LUAD | cg13069100 | chr1:155062532 | CGI:chr1:155062449-155064102 | promoter | 3.71e-01 | 4.73e-01 | -4.15e+00 | 3.28e-05 | 1.11e-04 | -1.01e-01 |
| LUSC | cg00585901 | chr1:155062912 | CGI:chr1:155062449-155064102 | promoter | 4.18e-02 | 2.41e-01 | -4.23e+00 | 2.39e-05 | 5.26e-04 | -1.99e-01 |
| LUSC | cg18832152 | chr1:155062707 | CGI:chr1:155062449-155064102 | promoter | 1.63e-01 | 3.10e-01 | -4.20e+00 | 2.65e-05 | 5.26e-04 | -1.47e-01 |
| LUSC | cg11491247 | chr1:155063054 | CGI:chr1:155062449-155064102 | promoter | 1.57e-01 | 3.15e-01 | -4.26e+00 | 2.02e-05 | 5.26e-04 | -1.58e-01 |
| LUSC | cg16905506 | chr1:155063272 | CGI:chr1:155062449-155064102 | promoter | 1.74e-01 | 3.81e-01 | -4.24e+00 | 2.20e-05 | 5.26e-04 | -2.07e-01 |
| LUSC | cg23008177 | chr1:155064101 | CGI:chr1:155062449-155064102 | promoter,gene body | 2.81e-01 | 9.04e-02 | 4.29e+00 | 1.78e-05 | 5.26e-04 | 1.91e-01 |
| KIRP | cg16905506 | chr1:155063272 | CGI:chr1:155062449-155064102 | promoter | 2.07e-01 | 3.39e-01 | -4.43e+00 | 9.59e-06 | 3.60e-05 | -1.32e-01 |
| ESCA | cg23008177 | chr1:155064101 | CGI:chr1:155062449-155064102 | promoter,gene body | 2.97e-01 | 1.75e-01 | 2.68e+00 | 7.35e-03 | 3.54e-02 | 1.22e-01 |
| CHOL | cg13069100 | chr1:155062532 | CGI:chr1:155062449-155064102 | promoter | 3.42e-01 | 4.59e-01 | -2.51e+00 | 1.22e-02 | 2.39e-02 | -1.17e-01 |
| CHOL | cg16905506 | chr1:155063272 | CGI:chr1:155062449-155064102 | promoter | 1.85e-01 | 3.39e-01 | -3.10e+00 | 1.96e-03 | 1.07e-02 | -1.54e-01 |
Differentially expressed CpG sites between female tumor and female normal patients. |
| Cancer Type | CpG Site | Position | CpG Island | Position to Gene | ave1 | ave2 | wilcoxon.w | wilcoxon.p | padj | dBeta |
| BRCA | cg23008177 | chr1:155064101 | CGI:chr1:155062449-155064102 | promoter,gene body | 2.46e-01 | 1.16e-01 | 1.21e+01 | 1.01e-33 | 2.43e-32 | 1.30e-01 |
| HNSC | cg13069100 | chr1:155062532 | CGI:chr1:155062449-155064102 | promoter | 5.40e-01 | 4.00e-01 | 2.58e+00 | 9.91e-03 | 1.85e-02 | 1.40e-01 |
Top |
Exon skipping events with PSI in TCGA for EFNA4 |
| ∗Please access ExonSkipDB for exon skipping annotation. |
Differentially expressed exon skipping events between male tumor and female tumor patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between male tumor and male normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Differentially expressed exon skipping events between female tumor and female normal patients. |
| Cancer Type | Exon Skipping | ave.female_T | ave.female_N | wilcoxon.w | wilcoxon.p | padj | dPSI |
Top |
RNA A-to-I editing events in TCGA for EFNA4 |
| ∗Please access CAeditome for RNA editing annotation. |
Differentially expressed RNA editing events between male tumor and female tumor patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between male tumor and male normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Differentially expressed RNA editing events between female tumor and female normal patients. |
| Cancer Type | Transcript | Editing | ave.male_T | ave.female_T | wilcoxon.w | wilcoxon.p | p_adj | dFre |
Protein coding RNA editing(s). |
| Editing Position | Variant Type | Gene Symbol | Transcript ID | NTchange | AAchange |
Top |
Sex-biased TF-Gene network for EFNA4 |
TFs related to EFNA4.∗The female-biased TF-gene edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased TF-gene edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | TF | Target Gene | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
| BRCA | HIC1 | EFNA4 | 3.07e+00 | 3.69e-03 | 4.60e+00 | 9.88e-01 | Female-biased |
| BRCA | HIC2 | EFNA4 | 2.82e+00 | 4.48e-03 | 4.28e+00 | 9.81e-01 | Female-biased |
| BRCA | KLF3 | EFNA4 | 2.54e+00 | 2.04e-03 | 4.25e+00 | 9.82e-01 | Female-biased |
| BRCA | MYC | EFNA4 | 2.64e+00 | 1.61e-03 | 4.43e+00 | 9.87e-01 | Female-biased |
| BRCA | NHLH1 | EFNA4 | 2.28e+00 | 1.00e-03 | 4.21e+00 | 9.82e-01 | Female-biased |
| BRCA | PLAGL2 | EFNA4 | 2.42e+00 | 2.08e-04 | 4.81e+00 | 9.94e-01 | Female-biased |
| BRCA | ZNF101 | EFNA4 | 2.53e+00 | 1.78e-03 | 4.28e+00 | 9.84e-01 | Female-biased |
| BRCA | ZNF28 | EFNA4 | 2.55e+00 | 1.15e-03 | 4.44e+00 | 9.88e-01 | Female-biased |
| BRCA | ZNF331 | EFNA4 | 2.33e+00 | 8.85e-04 | 4.30e+00 | 9.85e-01 | Female-biased |
| BRCA | ZNF682 | EFNA4 | 2.70e+00 | 3.36e-03 | 4.25e+00 | 9.81e-01 | Female-biased |
| BRCA | ZNF891 | EFNA4 | 2.45e+00 | 1.41e-03 | 4.27e+00 | 9.84e-01 | Female-biased |
EFNA4 related gene.∗Only the gene encode TF might with this result. ∗For more information please check Sex-biased TF-Coding gene network. |
Top |
Sex-biased RBP-ES network for EFNA4 |
RBPs related to ES in EFNA4.∗The female-biased RBP-ES edges were identified if Female_Edge_threshold>0.98 and Male_Edge_threshold<=0.98. ∗The male-biased RBP-ES edges were identified if Male_Edge_threshold>0.98 and Female_Edge_threshold<=0.98. |
| Cancer Type | RBP | Target ES | Male Edge Score | Male Edge Threshold | Female Edge Score | Female Edge Threshold | Type |
EFNA4 related ES.∗Only the gene encode RBP might with this result. ∗For more information please check Sex-biased RBP-ES network in cancer. |
Top |
Sex-biased CeRNA regulation of gene |
Sex-biased CeRNA regulation of gene. |
| Gene ID | ceRNA(lncRNA-miRNA-mRNA) | Group | Cancer Type |
| ENSG00000243364 | AC010615.2,hsa-mir-340,EFNA4 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000243364 | AC026191.1,hsa-mir-340,EFNA4 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000243364 | LINC00858,hsa-mir-340,EFNA4 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000243364 | AC099342.1,hsa-mir-340,EFNA4 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000243364 | RUSC1-AS1,hsa-mir-340,EFNA4 | Male-specific ceRNA | TCGA-BLCA |
| ENSG00000243364 | SNHG1,hsa-mir-340,EFNA4 | Male-specific ceRNA | TCGA-BLCA |
Top |
Sex-biased eQTL regulation of gene |
Sex-biased eQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| eQTL | Description |
Male-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs12036538 | chr1:161770010:A:T | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs4657104 | chr1:161770836:A:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs4494120 | chr1:161771610:C:T | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs2340823 | chr1:161776888:T:C | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs59199825 | chr1:161777881:C:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs16844014 | chr1:161777883:A:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs2070151 | chr1:161778266:C:T | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs10799979 | chr1:161778862:C:T | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs12407741 | chr1:161780225:C:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs6669440 | chr1:161781436:A:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs2271012 | chr1:161784051:G:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs1910480 | chr1:161784127:G:C | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs12037837 | chr1:161786278:G:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs6427630 | chr1:161787837:A:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs12045431 | chr1:161791155:C:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs12046853 | chr1:161791159:A:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs12047724 | chr1:161791272:T:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs1135983 | chr1:161791522:C:T | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs10917946 | chr1:161792834:G:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs12409812 | chr1:161793939:G:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs75309567 | chr1:161794462:T:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs59021559 | chr1:161794514:A:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs2879841 | chr1:161797031:G:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs114002867 | chr1:161797810:G:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs2036494 | chr1:161799346:T:G | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs1394067 | chr1:161800856:T:C | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs12402256 | chr1:161801382:T:C | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs3738326 | chr1:161802452:G:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs16847590 | chr1:161804782:T:C | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs4656333 | chr1:161808028:T:C | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs4656334 | chr1:161808904:G:A | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs4657108 | chr1:161809374:T:C | - | 0.233368342028386 | 0.00657766647975828 | GBM | Female-baised eQTL |
| rs1779991 | chr1:162763619:C:T | - | -0.256374219678939 | 0.0198150914928433 | GBM | Female-baised eQTL |
| rs4657102 | chr1:161770624:T:A | - | 0.196136839851755 | 0.0399632412498168 | GBM | Female-baised eQTL |
| rs12405111 | chr1:161821937:C:A | - | 0.196136839851755 | 0.0399632412498168 | GBM | Female-baised eQTL |
| rs16860777 | chr1:161888802:C:G | - | 0.196136839851755 | 0.0399632412498168 | GBM | Female-baised eQTL |
| rs35429672 | chr1:145880861:T:C | - | 0.0750300982212719 | 0.00194627575200475 | LGG | Female-baised eQTL |
| rs10494309 | chr1:157148629:T:C | - | 0.0719189765844038 | 0.0157823736860072 | LGG | Female-baised eQTL |
| rs6679296 | chr1:157147835:A:T | - | 0.0718830273923898 | 0.0168267399067881 | LGG | Female-baised eQTL |
| rs11264622 | chr1:157145059:T:C | - | 0.0697907916462983 | 0.0255983802268671 | LGG | Female-baised eQTL |
| rs373691590 | chr1:158953474:C:A | - | 0.117506106206063 | 0.0264198041611761 | LGG | Female-baised eQTL |
| rs6656937 | chr1:161924302:G:C | - | -0.0544285281204623 | 0.0265751540548528 | LGG | Female-baised eQTL |
| rs10800109 | chr1:161927216:G:A | - | -0.0544285281204623 | 0.0265751540548528 | LGG | Female-baised eQTL |
| rs7516104 | chr1:161932855:T:G | - | -0.0544285281204623 | 0.0265751540548528 | LGG | Female-baised eQTL |
| rs16827987 | chr1:161936002:T:C | - | -0.0544285281204623 | 0.0265751540548528 | LGG | Female-baised eQTL |
| rs10737517 | chr1:161938548:G:A | - | -0.0544285281204623 | 0.0265751540548528 | LGG | Female-baised eQTL |
| rs4657127 | chr1:161941965:C:T | - | -0.0544285281204623 | 0.0265751540548528 | LGG | Female-baised eQTL |
| rs4657319 | chr1:163943286:G:C | - | 0.103981608893176 | 0.0282913632078861 | LGG | Female-baised eQTL |
| rs857789 | chr1:158815904:A:C | - | -0.0637917793001886 | 0.0304447036703303 | LGG | Female-baised eQTL |
| rs6682753 | chr1:158951999:G:T | - | 0.101474654920603 | 0.0335198294021932 | LGG | Female-baised eQTL |
| rs10753679 | chr1:161923146:C:A | - | -0.0529123194836031 | 0.0349233497350104 | LGG | Female-baised eQTL |
| rs6688754 | chr1:158959129:G:C | - | 0.113246642299332 | 0.0350816018511948 | LGG | Female-baised eQTL |
| rs6671373 | chr1:161921006:C:G | - | -0.0566690167789984 | 0.0358083477442591 | LGG | Female-baised eQTL |
| rs7417576 | chr1:161927708:C:G | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10918214 | chr1:161929671:G:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10918215 | chr1:161929941:G:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs7514053 | chr1:161933245:A:G | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs4570397 | chr1:161933893:C:T | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs2341481 | chr1:161934708:G:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10918224 | chr1:161936323:G:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10918225 | chr1:161936415:G:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10753685 | chr1:161936692:C:T | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10753686 | chr1:161936880:A:G | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10918227 | chr1:161937276:G:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs12142836 | chr1:161937844:C:T | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10737518 | chr1:161938601:T:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs4657124 | chr1:161939809:G:C | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs4657125 | chr1:161940173:C:T | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs4657126 | chr1:161940249:A:G | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10159039 | chr1:161941583:G:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10800137 | chr1:161942942:G:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10733046 | chr1:161943462:C:A | - | -0.0521096733431831 | 0.0376087242144695 | LGG | Female-baised eQTL |
| rs10800106 | chr1:161923222:T:C | - | -0.0521189767184822 | 0.0379283279647299 | LGG | Female-baised eQTL |
| rs12562272 | chr1:161946350:T:C | - | -0.0521189767184822 | 0.0379283279647299 | LGG | Female-baised eQTL |
| rs2341480 | chr1:161926148:G:T | - | -0.0536571499441976 | 0.0431340153745562 | LGG | Female-baised eQTL |
| rs12044241 | chr1:152472235:G:A | - | 0.103434707964321 | 0.000736682862633373 | LUAD | Female-baised eQTL |
| rs10888490 | chr1:152473617:T:C | - | 0.103434707964321 | 0.000736682862633373 | LUAD | Female-baised eQTL |
| rs61815564 | chr1:152462692:C:A | - | 0.101110026344709 | 0.000942150369517951 | LUAD | Female-baised eQTL |
| rs12567242 | chr1:152464548:G:A | - | 0.101110026344709 | 0.000942150369517951 | LUAD | Female-baised eQTL |
| rs11205005 | chr1:152464972:T:A | - | 0.101110026344709 | 0.000942150369517951 | LUAD | Female-baised eQTL |
| rs12081541 | chr1:152468890:T:C | - | 0.101110026344709 | 0.000942150369517951 | LUAD | Female-baised eQTL |
| rs144881827 | chr1:152472624:C:T | - | 0.100117759627098 | 0.00115399770182024 | LUAD | Female-baised eQTL |
| rs1853690 | chr1:157378559:A:T | - | -0.0574849696930929 | 0.0273630053353023 | LUAD | Female-baised eQTL |
| rs10793697 | chr1:147038047:C:G | - | -0.0613833927684744 | 0.0318558709407399 | LUAD | Female-baised eQTL |
| rs1969871 | chr1:147038647:G:A | - | -0.0613833927684744 | 0.0318558709407399 | LUAD | Female-baised eQTL |
| rs10793698 | chr1:147038246:C:T | - | -0.0605671861319297 | 0.0366132733069865 | LUAD | Female-baised eQTL |
| rs1853783 | chr1:147037471:C:T | - | -0.0603426719550807 | 0.0384583511146526 | LUAD | Female-baised eQTL |
| rs10793699 | chr1:147038256:A:T | - | -0.0600157559314403 | 0.0399006168375224 | LUAD | Female-baised eQTL |
| rs72999485 | chr1:154586884:G:C | - | 0.0854676308072523 | 0.0422767406377621 | LUAD | Female-baised eQTL |
| rs61300392 | chr1:154603209:A:T | - | 0.0854676308072523 | 0.0422767406377621 | LUAD | Female-baised eQTL |
| rs73001418 | chr1:154613118:T:A | - | 0.0854676308072523 | 0.0422767406377621 | LUAD | Female-baised eQTL |
| rs73001420 | chr1:154614283:C:G | - | 0.0854676308072523 | 0.0422767406377621 | LUAD | Female-baised eQTL |
Female-specific eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Effect Score | FDR | Cancer Type | Biased Type |
| rs77829725 | chr1:162677591:C:G | - | 0.0871778942367254 | 0.0483615492864884 | LIHC | Male-baised eQTL |
| rs6427418 | chr1:158059057:A:T | - | -0.101228229170744 | 0.0423587702856928 | LUAD | Male-baised eQTL |
| rs13376489 | chr1:158815857:C:A | - | -0.0607259327619151 | 0.00633864146017727 | COAD | Male-baised eQTL |
| rs75699174 | chr1:158820990:T:C | - | -0.093909770990289 | 0.0377767897048153 | COAD | Male-baised eQTL |
| rs58608164 | chr1:158825602:T:A | - | -0.0930384667813701 | 0.0414256081269924 | COAD | Male-baised eQTL |
| rs201638960 | chr1:158827556:T:C | - | -0.0930384667813701 | 0.0414256081269924 | COAD | Male-baised eQTL |
Opposite sex-biased eQTL regulation. |
| SNP ID | SNP Info | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Sex-biased Gene in Cancer | Cancer Type |
Top |
Sex-biased eQTM regulation of gene |
Sex-biased eQTM regulation of gene (The figures only show the pairs with FDR<1e-5. For more information please check the below table). |
Male-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg13069100 | chr1:155062532 | promoter | -0.116240349608279 | 3.41653550536908e-08 | -0.335476388352583 | 3.946558329565651e-11 | HNSC |
Female-specific eQTM regulation. |
| CpG Site | CpG Postion | Position to Gene | Effect Score | FDR | Cor.r | Cor.Pvalue | Cancer Type |
| cg23008177 | chr1:155064101 | gene,promoter | 0.0490856867302088 | 6.42035831679507e-05 | 0.31273718049265975 | 3.4339932328943375e-07 | LUAD |
Opposite sex-biased eQTM regulation. |
| CpG Site | CpG Postion | CpG Island | Position to Gene | Male Effect | Male FDR | Female Effect | Female FDR | Male Cor | Male P-value | Female Cor | Female P-value | Sex-biased Coding Gene | Cancer Type |
Top |
Sex-biased sQTL regulation of gene |
Sex-biased sQTL regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTL | Description |
Male-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Female-specific sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Effect Score | FDR | Cancer Type | Biased Type |
Opposite sex-biased sQTL regulation. |
| ES ID | Skipped Exon | ORF Anno | SNP ID | SNP Info | SNP Position to ES | Male Effect | Male FDR | Female Effect | Female FDR | Cancer Type |
Top |
Sex-biased sQTM regulation of gene |
Sex-biased sQTM regulation of gene (The figures only show the pairs with FDR <1e-5. For more information please check the below table). |
| sQTM | Description |
Male-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Female-specific sQTM regulation. |
| EX ID | Skipped Exon | CPG Site | CPG Position | Position to EX Events | Effect Score | FDR | Cor.r | Cor.Pvalue | ORF_anno | Cancer Type |
Opposite sex-biased sQTM regulation. |
| EX ID | EX Info | Skipped Exon | CPG Site | CPG Position | CPG Island | Position to EX Events | Male Effect | Male FDR | Female Effect | Female FDR | Male Correlation | Male P-value | Female Correlation | Female P-value | ORF_anno | Cancer Type |
Top |
Related disease information of EFNA4 |
Diseases associated with this gene (DisGeNET). |
| Gene ID | Gene Symbol | Disease ID | Disease Name | Number of PMID | Source |